ZYRTEC ALLERGY (CETIRIZINE HYDROCHLORIDE) TABLET, FILM COATED [JOHNSON & JOHNSON CONSUMER INC., MCNEIL CONSUMER HEALTHCARE DIVISION]

  • Home
  • ZYRTEC ALLERGY (CETIRIZINE HYDROCHLORIDE) TABLET, FILM COATED [JOHNSON & JOHNSON CONSUMER INC., MCNEIL CONSUMER HEALTHCARE DIVISION]

ZYRTEC ALLERGY (CETIRIZINE HYDROCHLORIDE) TABLET, FILM COATED [JOHNSON & JOHNSON CONSUMER INC., MCNEIL CONSUMER HEALTHCARE DIVISION]
PDF | XML
NDC 50580-726-03, 50580-726-13, 50580-726-30, 50580-726-32, 50580-726-36, 50580-726-38, 50580-726-40, 50580-726-50, 50580-726-51, 50580-726-66, 50580-726-70, 50580-726-90, 50580-726-91, 50580-726-92, 50580-726-93
Set ID b165db38-b302-4220-8627-77cb07bb078c
Category HUMAN OTC DRUG LABEL
Packager Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division
Generic Name
Product Class
Product Number
Application Number NDA019835
View All Sections
  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • Active ingredient (in each tablet)

    Cetirizine HCl 10 mg

  • Purpose

    Antihistamine

  • Uses

    temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

    • runny nose
    • sneezing
    • itchy, watery eyes
    • itching of the nose or throat
  • Warnings

    Do not use if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine.

    Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.

    Ask a doctor or pharmacist before use if you are taking tranquilizers or sedatives.

    When using this product

    • drowsiness may occur
    • avoid alcoholic drinks
    • alcohol, sedatives, and tranquilizers may increase drowsiness
    • be careful when driving a motor vehicle or operating machinery

    Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

    If pregnant or breast-feeding

    • if breast-feeding: not recommended
    • if pregnant: ask a health professional before use.

    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

  • Directions

    adults and children 6 years and overone 10 mg tablet once daily; do not take more than one 10 mg tablet in 24 hours. A 5 mg product may be appropriate for less severe symptoms.
    adults 65 years and overask a doctor
    children under 6 years of ageask a doctor
    consumers with liver or kidney diseaseask a doctor
  • Other information

    • store between 20° to 25°C (68° to 77°F)
    • do not use if clamshell is opened, or if foil inner seal imprinted with "ZYRTEC®" is broken or missing
    • meets USP Dissolution Test 2
  • Inactive ingredients

    colloidal silicon dioxide, croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, titanium dioxide

  • Questions?

    call 1-800-343-7805 (toll-free) or 215-273-8755 (collect)

  • PRINCIPAL DISPLAY PANEL

    Original Prescription Strength

    NDC 50580-726-36

    ZYRTEC®
    ALLERGY

    Cetirizine HCl tablets
    10 mg /antihistamine

    Indoor & Outdoor Allergies

    24
    hour

    Relief of

    • Sneezing
    • Runny Nose
    • Itchy, Watery Eyes
    • Itchy Throat or Nose

    30 Tablets
    10 mg each

    (Actual Size)

    PRINCIPAL DISPLAY PANEL
  • INGREDIENTS AND APPEARANCE
    ZYRTEC ALLERGY 
    cetirizine hydrochloride tablet, film coated
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:50580-726
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    Cetirizine Hydrochloride (UNII: 64O047KTOA) (Cetirizine - UNII:YO7261ME24) Cetirizine Hydrochloride10 mg
    Inactive Ingredients
    Ingredient NameStrength
    Silicon Dioxide (UNII: ETJ7Z6XBU4)  
    Croscarmellose Sodium (UNII: M28OL1HH48)  
    Hypromellose, Unspecified (UNII: 3NXW29V3WO)  
    Lactose Monohydrate (UNII: EWQ57Q8I5X)  
    Magnesium Stearate (UNII: 70097M6I30)  
    Microcrystalline Cellulose (UNII: OP1R32D61U)  
    Polyethylene Glycol, Unspecified (UNII: 3WJQ0SDW1A)  
    Titanium Dioxide (UNII: 15FIX9V2JP)  
    Product Characteristics
    ColorWHITEScore2 pieces
    ShapeRECTANGLE (rounded-off rectangular biconvex tablet) Size9mm
    FlavorImprint Code ZYRTEC;10;MG
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:50580-726-0350 in 1 CARTON01/01/2008
    11 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC:50580-726-133 in 1 CARTON03/21/2009
    21 in 1 BLISTER PACK; Type 0: Not a Combination Product
    3NDC:50580-726-305 in 1 PACKAGE01/01/2008
    31 in 1 BLISTER PACK; Type 0: Not a Combination Product
    4NDC:50580-726-3214 in 1 PACKAGE01/01/2008
    41 in 1 BLISTER PACK; Type 0: Not a Combination Product
    5NDC:50580-726-361 in 1 PACKAGE01/01/2008
    530 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
    6NDC:50580-726-501 in 1 PACKAGE01/26/2010
    650 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
    7NDC:50580-726-512 in 1 PACKAGE01/26/2010
    750 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
    8NDC:50580-726-381 in 1 PACKAGE01/01/2008
    845 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
    9NDC:50580-726-701 in 1 PACKAGE01/01/2008
    970 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
    10NDC:50580-726-902 in 1 PACKAGE01/26/2010
    1045 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
    11NDC:50580-726-6675 in 1 PACKAGE, COMBINATION; Type 0: Not a Combination Product01/01/2008
    12NDC:50580-726-401 in 1 PACKAGE01/20/2014
    1240 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
    13NDC:50580-726-912500 in 1 CARTON07/27/2018
    131 in 1 POUCH; Type 0: Not a Combination Product
    14NDC:50580-726-9250 in 1 TRAY07/12/2018
    141 in 1 POUCH; Type 0: Not a Combination Product
    15NDC:50580-726-933 in 1 CARTON07/27/2018
    151 in 1 POUCH; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    NDANDA01983501/01/2008
    Labeler - Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division (878046358)
View All Sections

Related Drugs

Search DailyMed Drugs